Intraoperative Radiation Therapy Market Analysis and Forecast to 2031: By Product & Service (Products, Services), Technology (Electron IORT, Intraoperative Brachytherapy), Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head & Neck Cance

Intraoperative Radiation Therapy Market Analysis and Forecast to 2031: By Product & Service (Products, Services), Technology (Electron IORT, Intraoperative Brachytherapy), Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head & Neck Cancer, Colorectal Cancer, Endometrial & Cervical Cancer, Lung Cancer, Other), and Region

The intraoperative radiation therapy market was valued at USD 50.00 million in 2021 and it is anticipated to grow further till USD 92.5 million by 2031, at a CAGR of 6.3% during the forecast period.

Intraoperative radiation therapy systems (IORT) administer a concentrated dose of radiation to a tumor site right away following the removal of a tumor in order to eradicate the microscopic malignant cells. The spectrum is utilized to determine the type of microorganisms present inside the cells due to intra beam or differential radiation properties. IORT refers to the delivery of therapeutic radiation doses to the tumor location. Along with outer beam radiation, chemotherapy, and surgery, IORT is frequently used in the multidisciplinary management of privately advanced and recurrent illnesses. As a recent development, IORT can also be applied to earlier stages of diseases like prostate cancer and breast cancer growth.

Market Trends and Drivers

The IORT technique has a number of benefits, including focused radiation, brief treatments, excellent radiation control, and less radiation exposure to healthy tissue. This is particularly true in the case of breast cancer, as this mode provides women with a selection of breast-preserving treatments (lumpectomy). Therefore, one of the major factors fueling the market's expansion is the rising incidence of breast cancer. The use of IORT procedures will increase due to the rising incidence of cancer.

Similarly, as a breast-conserving procedure, IORT has developed a number of noteworthy uses throughout time. A significant number of manufacturers and research institutions are working together more frequently to perform clinical trials to examine the applicability and efficacy of IORT for additional cancer types as a result of technological developments in this area combined with the expanding uses of IORT. These clinical trials' main objective is to assess the viability of IORT therapy for a range of cancer applications.

Market Restraints and Challenges

To achieve the greatest tumor control and ensure the least amount of harm to normal tissue, a high degree of accuracy is required at every stage of the procedure. Interconnectivity problems across various treatment planning, delivery, and monitoring systems can lead to procedural errors, which increases patient risks. These IORT-related complications make it difficult for this therapy to become widely used in the treatment of cancer.

Global Intraoperative Radiation Therapy Market Segmental Overview

The report analyses the global intraoperative radiation therapy market based on the product service, technology, application, and region.

Global Intraoperative Radiation Therapy Market by Product Service

Based on the product service, it is segmented into products services. The products segment is also sub-segmented into systems/accelerators, applicators after loaders, treatment planning systems, and accessories. The products segment is anticipated to dominate the market during the forecast period. The increased market share in this sector can be due to factors such as their expanding availability, the creation of technologically sophisticated mobile systems and accelerators, treatment planning, and the expanding use of IORT products in the treatment of cancer.

Global Intraoperative Radiation Therapy Market by Technology

Based on the technology, it is segmented into electron IORT, and intraoperative brachytherapy. The electron IORT segment is anticipated to dominate the market during the forecast period. This market's expansion can be ascribed to a host of advantages, such as shorter treatment times, improved depth of penetration, and homogeneous doses that work best.

Global Intraoperative Radiation Therapy Market by Application

Based on the application, it is segmented into breast cancer, brain tumor, gastrointestinal cancer, head neck cancer, colorectal cancer, endometrial cervical cancer, lung cancer, and others. The breast cancer application segment is anticipated to dominate the market during the forecast period. The non-invasive nature of radiotherapy, the increase in breast cancer cases, and the high success rates with IORT are the main causes of this.

Geographical Analysis of the Global Intraoperative Radiation Therapy Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America is anticipated to hold the largest share of the intraoperative radiation therapy market. The rising incidence of cancer, the widespread use of IORT for cancer therapy, and the high annual per capita healthcare spending in the US and Canada are the main factors propelling market expansion in this area. The use of low-energy IORT has also been promoted by organizations like the American Society for Radiation Oncology (ASTRO), which has helped to improve its uptake in North America.

Major Players in the Global Intraoperative Radiation Therapy MarketCOVID-19 Impact

The COVID-19 epidemic has a substantial effect on the market for intraoperative radiation therapy. Hospitals and cancer treatment facilities had to restrict or delay a number of screening, diagnostic, and surgical operations, which caused disruptions in the market for cancer detection and treatment. The epidemic also had an effect on the resources available for medical care. Major regulatory agencies from around the world, including the CDC, WHO, MHRA, TGA, and EMA, have noted that people with cancer are more likely than healthy adults to get coronavirus illness. Regulatory authorities proposed a few alternative dose-fractionation regimens to lessen the load on the patient and personnel while lowering the danger of exposure.

Recent Developments

• February 2022, Karnataka’s first IORT system for breast cancer treatment installed at Fortis.
• April 2020, Elekta AB launched Geneva, a universal gynecological applicator for brachytherapy.
• May 2019, Varian acquired Cancer Treatment Service International, a US based oncology solutions divisions that provides cancer care professional service to healthcare providers across the globe. The acquisition expanded Varian’s access to technology driven cancer care.
• October 2018, Varian launched the Bravos after loaders system for high-dose-rate brachytherapy treatments.

Frequently Asked QuestionsQ1. How big is the Intraoperative Radiation Therapy market?Ans. The global Intraoperative Radiation Therapy market size was USD 50.00 Million in 2021 and is anticipated to reach USD 92.5 Million in 2031, growing at a rate of 6.3% from 2022 to 2031.Q2. What is the Intraoperative Radiation Therapy market growth rate?Ans. The growth rate of the Intraoperative Radiation Therapy market is 6.3%.Q3. Which region holds a major market share for the Intraoperative Radiation Therapy market?Ans. North America holds a major market share of the Intraoperative Radiation Therapy market in 2021.Q4. Which segment accounted for the largest Intraoperative Radiation Therapy market share?Ans. By application, breast cancer segment accounted for the largest Intraoperative Radiation Therapy market share.Q5. Who are the key players in the Intraoperative Radiation Therapy market?Q6. What are the factors driving the Intraoperative Radiation Therapy market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.Q7. What are the key growth strategies of Intraoperative Radiation Therapy market players?Ans. The key growth strategies of Intraoperative Radiation Therapy market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Intraoperative Radiation Therapy market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Intraoperative Radiation Therapy market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.